Camilla Qvortrup

Camilla Qvortrup

Clinical Associate Professor

Member of:

  • Clinical Oncology


Publication year:
  1. 2022
  2. Published

    Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact

    Jacobsen, I. C., Spanggaard, I., Højgaard, M., Belcaid, L., Qvortrup, Camilla, Yde, C. W., Schmidt, A. Y., Nielsen, Finn Cilius, Willemoe, G. L., Dam, M. S., Lassen, Ulrik Niels & Staal Rohrberg, K., 2022, In: Acta Oncologica. 61, 12, p. 1499-1506 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    TP53 mutations are frequently concurrent in patients with BRAF V600E mutated solid tumors and is associated with shorter duration of response to BRAF targeted therapy

    Eriksen, M., Yde, C. W., Ahlborn, L. B., Qvortrup, Camilla, Lassen, Ulrik Niels, Højgaard, M., Spanggaard, I. & Rohrberg, K. S., 2022, In: European Journal of Cancer. 174, S1, p. S118

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Published

    ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis

    Gögenur, M., Hadi, N. A. H., Qvortrup, Camilla, Andersen, C. L. & Gögenur, Ismail, 2022, In: Annals of Surgical Oncology. 29, 13, p. 8666-8674

    Research output: Contribution to journalReviewResearchpeer-review

  5. 2021
  6. Published

    Colorectal cancer screening in Europe: what are the next steps?

    Gögenur, Ismail & Qvortrup, Camilla, 2021, In: The Lancet Oncology. 22, 7, p. 898-899 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

Previous 1 2 Next

ID: 283356767